Evaluation of The Effect of 10% Lidocaine Spray on Reducing the Pain of IUD Insertion

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT2017042333608N1

Enrollment

Registered

2017-10-15

Start date

2014-03-11

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

The Effect of 10% Lidocaine Spray on Reducing the Pain of IUD Insertion. -

Interventions

Intervention 1: The intervention group received local anesthetic by four puffs of 10% lidocaine (40 mg) at cervical area three minutes prior to IUD insertion. Intervention 2: The control group (routin

Prevention

The intervention group received local anesthetic by four puffs of 10% lidocaine (40 mg) at cervical area three minutes prior to IUD insertion

The control group (routine IUD insertion without analgesia)

Eligibility

Sex/Gender

Female

Age

18 Years to 45 Years

Inclusion criteria

Inclusion criteria: Inclusion Criteria: No allergies to Lidocaine; Haven't received analgesics and narcotics during the 24 hours before IUD insertion; History of childbirth up to 3 times; no any contraindication for IUD insertion (suspected pregnancy; history of pelvic inflammatory disease; abnormal uterine anatomy; Wilson’s disease; unexplained vaginal bleeding and cervical malignancy) Exclusion Criteria: Problem to IUD insertion; uterine size smaller than 6 cm or larger than 9 cm.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Pain. Timepoint: Pain at baseline and during and after IUD insertion. Method of measurement: Visual Scale Analog.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMaryam Hajiesmaello

Urmia Branch, Islamic Azad University

mhajiesmaello@yahoo.com; m.hajiesmailou@iaurmia.ac.ir+98 44 3272 2701

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026